Related references
Note: Only part of the references are listed.BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Addressing Missing Data in Clinical Trials
Thomas R. Fleming
ANNALS OF INTERNAL MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Strategies for treating idiopathic pulmonary fibrosis
R. M. du Bois
NATURE REVIEWS DRUG DISCOVERY (2010)
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
David A. Zisman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
Jeffrey J. Swigris et al.
THORAX (2010)
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King et al.
LANCET (2009)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Acute exacerbations of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival
Robin M. Rudd et al.
THORAX (2007)
Incidence and prevalence of idiopathic pulmonary fibrosis
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Analyses of efficacy end points in a controlled trial of interferon-gamma 1b for idiopathic pulmonary fibrosis
TE King et al.
CHEST (2005)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends
PI Latsi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia
KR Flaherty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
HR Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Idiopathic pulmonary fibrosis - A composite physiologic index derived from disease extent observed by computed tomography
AU Wells et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Clinical significance of histological classification of idiopathic interstitial pneumonia
KR Flaherty et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model
TE King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)